Jessica Nell McAlpine

24PUBLICATIONS
205CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsMedical mycologyCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Feb 13, 2026
Re-Evaluating the Progesterone Challenge Test as a Physiologic Marker of Endometrial Cancer Risk: A Systematic Review and Meta-Analysis.

Rachel J Woima, Derek S Chiu, Elise Abi Khalil

|Feb 03, 2026
The Progesterone Challenge Test as a Functional Biomarker of Endometrial Cancer Risk: Results from a Prospective Feasibility Study.

Andrea Neilson, Rachel Woima, Dollina Dodani

|Apr 14, 2025
Activated immune infiltrates expand opportunities for targeted therapy in p53-abnormal endometrial carcinoma.

Spencer D Martin, Shelby Thornton, Christine Chow

|Jan 15, 2025
Prognostic values of molecular subtypes and SWI/SNF protein expression in de-differentiated/undifferentiated endometrial carcinoma.

Chae Young Shin, Bengul Gokbayrak, Valerie L Tao

|Jan 08, 2025
Molecular Subtypes of Vulvar Squamous Cell Carcinoma: The Significance of HPV-Independent/p53 Wild Type.

Lars-Christian Horn, Christine E Brambs, Blake Gilks

|Dec 17, 2024
Papillary and ductal patterns of mesonephric-like adenocarcinomas are often overlooked: a retrospective revaluation of over 1000 endometrial carcinomas.

Ardalan Akbari, Jennifer Pors, Amy Lum

Pageof 4

Frequent Collaborators

7 joint publications

C Blake Gilks

6 joint publications

Amy Jamieson

6 joint publications

Aline Talhouk

4 joint publications

Samuel Leung